当前位置:首页 - 行情中心 - 热景生物(688068) - 财务分析 - 现金流量表

热景生物

(688068)

  

流通市值:81.86亿  总市值:81.86亿
流通股本:9275.41万   总股本:9275.41万

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金296,253,122.6189,026,695.87408,978,644.22293,346,991.83
  收到的税费返还-230,955.6669,166.99321,238.76
  收到其他与经营活动有关的现金15,577,459.246,622,804.33104,749,639.3764,588,632.93
  经营活动现金流入小计311,830,581.8595,880,455.8514,397,450.58358,256,863.52
  购买商品、接受劳务支付的现金99,752,511.6130,004,511.36156,737,237.1184,937,917.87
  支付给职工以及为职工支付的现金132,089,376.8953,612,851.63230,453,242.49149,545,504.71
  支付的各项税费14,325,214.523,472,976.2517,223,262.2412,624,307.69
  支付其他与经营活动有关的现金177,392,954.0469,227,646.84193,340,531.91109,903,118.74
  经营活动现金流出小计423,560,057.06156,317,986.08597,754,273.75357,010,849.01
  经营活动产生的现金流量净额-111,729,475.21-60,437,530.28-83,356,823.171,246,014.51
二、投资活动产生的现金流量:
  收回投资收到的现金1,427,254,489.02898,352,362.484,959,911,586.883,979,291,081.45
  取得投资收益收到的现金12,714,235.7321,345,423.8434,169,123.3632,031,713.28
  处置固定资产、无形资产和其他长期资产收回的现金净额31,801.81-1,699,834.4685,974.22
  处置子公司及其他营业单位收到的现金净额---3,000,000
  收到的其他与投资活动有关的现金---12,000
  投资活动现金流入小计1,440,000,526.56919,697,786.324,995,780,544.644,015,020,768.95
  购建固定资产、无形资产和其他长期资产支付的现金51,834,125.115,932,318.1543,573,509.9620,164,374.09
  投资支付的现金1,596,626,405.661,192,194,515.354,703,289,988.894,125,006,570.47
  支付其他与投资活动有关的现金-3,000-1,958.13
  投资活动现金流出小计1,648,460,530.761,208,129,833.54,746,863,498.854,145,172,902.69
  投资活动产生的现金流量净额-208,460,004.2-288,432,047.18248,917,045.79-130,152,133.74
三、筹资活动产生的现金流量:
  吸收投资收到的现金8,547,719.368,225,396.9737,680,977.283,524,377.28
  其中:子公司吸收少数股东投资收到的现金7,850,000-34,156,600-
  取得借款收到的现金--321,180,885.4350,000,000
  收到其他与筹资活动有关的现金97,727,962.66---
  筹资活动现金流入小计106,275,682.028,225,396.97358,861,862.7153,524,377.28
  偿还债务支付的现金50,000,00050,000,00046,824,118.98-
  分配股利、利润或偿付利息支付的现金46,959.6446,8751,744,539.6806,250
  支付其他与筹资活动有关的现金64,706,653.961,714,886.69222,518,136.0872,380,847.43
  筹资活动现金流出小计114,753,613.651,761,761.69271,086,794.6673,187,097.43
  筹资活动产生的现金流量净额-8,477,931.58-43,536,364.7287,775,068.05-19,662,720.15
四、汇率变动对现金及现金等价物的影响1,273,186.1-3,806,802.411,457,033.75-1,026,246.55
五、现金及现金等价物净增加额-327,394,224.89-396,212,744.59254,792,324.42-149,595,085.93
  加:期初现金及现金等价物余额536,833,364.72507,540,166.03282,041,040.3270,142,930.21
  期末现金及现金等价物余额209,439,139.83111,327,421.44536,833,364.72120,547,844.28
补充资料:
  净利润-158,809,512.56--258,634,919.3-
  资产减值准备-29,301.65-43,432,490.1-
  固定资产和投资性房地产折旧34,759,724.96-77,377,499.33-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧34,759,724.96-77,377,499.33-
  无形资产摊销1,837,658.39-4,075,422.23-
  长期待摊费用摊销4,085,613.18-7,318,854.35-
  处置固定资产、无形资产和其他长期资产的损失6,833.5--579,429.25-
  固定资产报废损失---2,386.87-
  公允价值变动损失15,250,973.5-37,762,937.31-
  财务费用7,764,323.38-8,897,267.67-
  投资损失-18,651,532.67--60,668,645.45-
  递延所得税-885,577.56--8,769,810.94-
  其中:递延所得税资产减少-875,664.35--8,779,724.15-
    递延所得税负债增加-9,913.21-9,913.21-
  存货的减少-7,124,169.5-13,387,684.12-
  经营性应收项目的减少-33,526,016.28-51,240,266.58-
  经营性应付项目的增加34,428,925.18--3,725,087.92-
  其他-978,996.15--301,450.19-
  现金的期末余额209,439,139.83-536,833,364.72-
  减:现金的期初余额536,833,364.72-282,041,040.3-
  现金及现金等价物的净增加额-327,394,224.89-254,792,324.42-
公告日期2026-08-272026-04-252026-04-252025-10-24
审计意见(境内)标准无保留意见
TOP↑